Age-Related Hemodynamic and Morphologic Differences in Patients Undergoing Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
スポンサーリンク
概要
- 論文の詳細を見る
Background Alcohol septal ablation (ASA) decreases the left ventricular (LV) outflow gradient and relieves symptoms in patients with highly symptomatic hypertrophic obstructive cardiomyopathy (HOCM). The aim of this study was to evaluate the early course of hemodynamic, morphologic and clinical changes in younger and elderly patients. Methods and Results Forty-four consecutive patients (age, 24-81 years) underwent the ASA procedure for HOCM. Clinical and echocardiographic data were obtained at baseline and periodically up to 12 months after ASA. There was a significant correlation between septum thickness and age at baseline and in the early post procedural period (p=0.004 at baseline, p=0.0033 days postoperative, p=0.0193 weeks pos operative). The dependence of septal thickness on the duration of follow-up (p<0.001) was significantly influenced by age (p=0.026), which retained statistical significance after multivariate adjustment (p=0.031). A decrease in the gradient of the LV outflow was identified in all age-related groups of patients (p<0.001). After multivariate adjustment, there was a significant influence of age (p=0.003) and creatine kinase-MB peak (p=0.016) on the course of outflow gradient reduction. Conclusions ASA is an effective treatment option for patients with HOCM, irrespective of their age. Younger patients are characterized by a thicker basal septum at baseline and a slower hemodynamic improvement within the early post procedural period.
- 社団法人日本循環器学会の論文
- 2006-06-20
著者
-
Hajek Petr
Cardio Vascular Center Department Of Cardiology University Hospital Motol
-
Veselka Josef
Cardio Vascular Center, Department of Cardiology, University Hospital Motol
-
Veselka Josef
Department of Cardiology, University Hospital Motol
-
Duchonova Radka
Department of Cardiology, University Hospital Motol
-
Palenickova Jana
Department of Cardiology, University Hospital Motol
-
Zemanek David
Department of Cardiology, University Hospital Motol
-
Svab Premysl
Department of Cardiology, University Hospital Motol
-
Hajek Petr
Department of Cardiology, University Hospital Motol
-
Maly Martin
Department of Cardiology, University Hospital Motol
-
Blasko Petr
Department of Cardiology, University Hospital Motol
-
Tesar David
Department of Imaging Methods, University Hospital Motol
-
Cervinka Pavel
Department of Cardiology, Hospital Usti n Labem
-
Blasko Petr
Cardio Vascular Center Department Of Cardiology University Hospital Motol
-
Palenickova Jana
Department Of Cardiology University Hospital Motol
-
Tesar David
Department Of Imaging Methods University Hospital Motol
-
Svab Premysl
Department Of Cardiology University Hospital Motol
-
Veselka Josef
Cardio Vascular Center Department Of Cardiology University Hospital Motol
-
Veselka Josef
Department Of Cardiology Cardiovascular Center University Hospital Motol
-
Zemanek David
Cardio Vascular Center Department Of Cardiology University Hospital Motol
-
Cervinka Pavel
Department Of Cardiology Hospital Usti N Labem
-
Duchonova Radka
Cardiovascular Center Department Of Cardiology University Hospital Motol
-
Zemanek David
Department of Cardiology, Cardiovascular Center, University Hospital Motol and 1st Medical School
関連論文
- Thirty-Day Outcomes of Direct Carotid Artery Stenting With Cerebral Protection in High-Risk Patients
- Age-Related Hemodynamic and Morphologic Differences in Patients Undergoing Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
- Impact of Ethanol Dosing on the Long-Term Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy : A Single-Center, Prospective, and Randomized Study
- Effect of MGuard Net Protective Stent on the Release of Troponin I in Patients With Acute Coronary Syndromes : A Randomized Controlled Trial
- Parathyroid Hormone and Vitamin D Levels are Independently Associated With Calcific Aortic Stenosis
- Infective Endocarditis After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy